Anika Therapeutics, Inc. (ANIK) quarterly balance sheet — complete assets, liabilities & equity history
| Total Current Assets | 93.56M | 103.36M | 101.59M | 99.32M | 102.51M | 113.65M | 136.11M | 155M | 158.96M | 163.31M | 156.78M | 152.2M |
| Cash & Short-Term Investments | 41.02M | 57.48M | 57.99M | 53.17M | 53.37M | 55.63M | 62.37M | 62.82M | 68.63M | 68.74M | 70.65M | 65.07M |
| Cash Only | 41.02M | 57.48M | 57.99M | 53.17M | 53.37M | 55.63M | 62.37M | 62.82M | 68.63M | 68.74M | 70.65M | 65.07M |
| Short-Term Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Accounts Receivable | 25.77M | 23.69M | 22.19M | 23.95M | 21.99M | 23.59M | 28.36M | 33.77M | 32.08M | 26.36M | 34.68M | 36.74M |
| Days Sales Outstanding | 75.16 | 68.93 | 76.3 | 74.08 | 78.38 | -1.85K | 73.75 | 97.52 | 65.61 | 65.34 | 79.23 | 69.19 |
| Inventory | 22.84M | 18.79M | 16.28M | 16.92M | 21.34M | 23.81M | 39.63M | 51.46M | 49.41M | 24.43M | 43.72M | 42.6M |
| Days Inventory Outstanding | 176.46 | 141.07 | 124.87 | 125.63 | 176.85 | -122.33 | 112.3 | 448.43 | 211.36 | 188.38 | 240.37 | 249.09 |
| Other Current Assets | 3.94M | 3.4M | 5.13M | 5.27M | 5.82M | 10.62M | 5.75M | 6.94M | 8.85M | 43.78M | 7.72M | 7.79M |
| Total Non-Current Assets | 85.83M | 86.91M | 87.85M | 88.36M | 88.1M | 89.09M | 95.3M | 107.66M | 104.78M | 107.32M | 171.38M | 176.68M |
| Property, Plant & Equipment | 65.15M | 66.26M | 64.91M | 65.81M | 65.64M | 64.68M | 71.78M | 75.45M | 74.24M | 65M | 74.99M | 77.62M |
| Fixed Asset Turnover | 0.45x | 0.47x | 0.43x | 0.43x | 0.40x | -0.02x | 0.53x | 0.41x | 0.58x | 0.61x | 0.54x | 0.57x |
| Goodwill | 7.89M | 8.05M | 8.05M | 8.06M | 7.42M | 7.13M | 7.66M | 7.35M | 7.4M | 7.57M | 7.25M | 7.47M |
| Intangible Assets | 1.65M | 1.65M | 1.65M | 1.66M | 2.28M | 2.49M | 3.08M | 3.97M | 4.3M | 2.58M | 68.76M | 70.71M |
| Long-Term Investments | 5.68M | 0 | 6.48M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Current Assets | 4.3M | 9.67M | 5.51M | 11.59M | 11.56M | 13.62M | 11.31M | 19.52M | 17.57M | 30.69M | 18.95M | 19.39M |
| Total Assets | 179.39M | 190.27M | 189.44M | 187.68M | 190.6M | 202.74M | 231.41M | 262.65M | 263.74M | 270.63M | 328.16M | 328.88M |
| Asset Turnover | 0.16x | 0.16x | 0.15x | 0.15x | 0.13x | -0.01x | 0.16x | 0.12x | 0.15x | 0.14x | 0.13x | 0.13x |
| Asset Growth % | -5.89% | -6.15% | -18.14% | -28.54% | -27.73% | -25.09% | -29.48% | -20.14% | -22.22% | -22.48% | -5.63% | -7.13% |
| Total Current Liabilities | 20.97M | 21.91M | 19.09M | 16.08M | 17.9M | 23.31M | 25.49M | 26.12M | 28.46M | 31.06M | 28.06M | 23.46M |
| Accounts Payable | 6.34M | 6.04M | 4.73M | 4.77M | 5.28M | 5.62M | 6.8M | 9.99M | 10.02M | 6.19M | 8.25M | 7.94M |
| Days Payables Outstanding | 52.48 | 43.33 | 35.73 | 33 | 42.68 | -23.95 | 20.71 | 88.98 | 46.42 | 39.93 | 45.09 | 50.14 |
| Short-Term Debt | 1.94M | 0 | 1.73M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Deferred Revenue (Current) | 229K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Current Liabilities | 2.75M | 15.87M | 2.87M | 7.06M | 7M | 12.16M | 12.5M | 9.96M | 8.76M | 18.73M | 10.97M | 8.69M |
| Current Ratio | 4.46x | 4.72x | 5.32x | 6.18x | 5.73x | 4.88x | 5.34x | 5.93x | 5.59x | 5.26x | 5.59x | 6.49x |
| Quick Ratio | 3.37x | 3.86x | 4.47x | 5.12x | 4.53x | 3.85x | 3.78x | 3.96x | 3.85x | 4.47x | 4.03x | 4.67x |
| Cash Conversion Cycle | 199.14 | 166.67 | 165.43 | 166.71 | 212.56 | -1.95K | 165.34 | 456.97 | 230.55 | 213.8 | 274.5 | 268.14 |
| Total Non-Current Liabilities | 24.52M | 24.9M | 23.54M | 23.93M | 24.31M | 25.45M | 26.05M | 26.2M | 26.75M | 27.31M | 29.61M | 31.41M |
| Long-Term Debt | 0 | 24.2M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Capital Lease Obligations | 23.79M | 0 | 22.78M | 23.17M | 23.56M | 24.01M | 25.24M | 25.79M | 26.34M | 25.91M | 27.25M | 27.77M |
| Deferred Tax Liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1.96M | 3.23M |
| Other Non-Current Liabilities | 726K | 701K | 761K | 756K | 744K | 1.43M | 806K | 407K | 404K | 1.39M | 400K | 401K |
| Total Liabilities | 45.49M | 46.8M | 42.63M | 40.01M | 42.21M | 48.75M | 51.54M | 52.32M | 55.21M | 58.37M | 57.67M | 54.87M |
| Total Debt | 25.74M | 24.2M | 24.51M | 24.99M | 25.44M | 25.93M | 27.53M | 28.08M | 28.47M | 27.74M | 29.31M | 29.86M |
| Net Debt | -15.28M | -33.28M | -33.48M | -28.18M | -27.93M | -29.7M | -34.83M | -34.75M | -40.16M | -41M | -41.34M | -35.21M |
| Debt / Equity | 0.19x | 0.17x | 0.17x | 0.17x | 0.17x | 0.17x | 0.15x | 0.13x | 0.14x | 0.13x | 0.11x | 0.11x |
| Debt / EBITDA | - | 12.32x | - | - | - | 0.88x | - | 113.21x | - | - | - | - |
| Net Debt / EBITDA | - | -16.95x | - | - | - | -1.00x | - | -140.10x | - | - | - | - |
| Interest Coverage | - | - | - | - | - | - | - | - | - | - | - | - |
| Total Equity | 133.9M | 143.47M | 146.81M | 147.67M | 148.4M | 153.99M | 179.86M | 210.34M | 208.54M | 212.26M | 270.49M | 274.01M |
| Equity Growth % | -9.77% | -6.83% | -18.38% | -29.79% | -28.84% | -27.45% | -33.5% | -23.24% | -24.88% | -25.67% | -5.07% | -4.24% |
| Book Value per Share | 9.90 | 9.78 | 10.18 | 10.28 | 10.38 | 10.46 | 12.18 | 14.17 | 14.19 | 14.49 | 18.48 | 18.66 |
| Total Shareholders' Equity | 133.9M | 143.47M | 146.81M | 147.67M | 148.4M | 153.99M | 179.86M | 210.34M | 208.54M | 212.26M | 270.49M | 274.01M |
| Common Stock | 133K | 139K | 144K | 144K | 143K | 144K | 147K | 148K | 148K | 147K | 146K | 147K |
| Retained Earnings | 55.73M | 60.79M | 60.49M | 62.82M | 66.79M | 71.67M | 93.53M | 123.45M | 123.54M | 128.05M | 191.05M | 197.63M |
| Treasury Stock | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Accumulated OCI | -5.31M | -4.96M | -4.94M | -4.75M | -6.1M | -6.78M | -5.7M | -6.42M | -6.32M | -5.94M | -6.56M | -6.16M |
| Minority Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |